Gary Brecka has built a substantial public profile around his role in Dana White’s dramatic health transformation, regularly pointing to it as proof that his supplement and nutrient deficiency protocols can work miracles.
But critics say the real story is far more straightforward than Brecka lets on.
During a recent appearance on The Dr. Phil Podcast, Brecka referenced the UFC president’s case while explaining his approach to high homocysteine levels.
“If you followed my journey with Dana White, he was a brittle hypertensive when I met him,” Brecka said, noting that White had been on multiple blood pressure medications that still couldn’t control his numbers.
Brecka attributed the turnaround to trimethylglycine, an amino acid supplement he says brings elevated homocysteine down and allows the arterial system to relax.
What Brecka consistently downplays, however, is that Dana White was also placed on testosterone replacement therapy. Brecka has previously acknowledged putting White on TRT but framed it as a minor footnote in the larger supplement-driven story.
Derek from the YouTube channel More Plates More Dates and competitive bodybuilder Stan Efferding have both pushed back hard on this narrative. Their position is that White’s improvements came from well-established, conventional interventions, not novel biohacking.
White lost roughly 35 lbs (about 15.9 kg), got his testosterone into a normal therapeutic range through TRT, and addressed textbook cardiovascular risk factors including obesity, elevated blood pressure, and extremely high triglycerides. According to Derek and Efferding, those changes alone account for virtually everything Brecka takes credit for.
On the Dr. Phil episode, Brecka also leaned heavily into concepts like telomere length as a biological age marker and the methylation-based genetic test he recommends to all his clients. He described MTHFR gene mutations, homocysteine metabolism, and nutrient deficiencies as the hidden root causes behind conditions that mainstream medicine labels idiopathic.
While some of these ideas have legitimate scientific footing, Derek and Efferding argue that Brecka consistently overstates the evidence, particularly around methylation as a longevity lever.
What critics find most problematic is the pattern: Brecka creates a sense of urgency by telling people their biological clock is running out and their body is starved of raw materials, which may well motivate lifestyle changes.
But when those changes work, the credit goes to the supplements and the proprietary testing protocol rather than the weight loss, the TRT, and the reduction in cardiovascular strain that drove the actual results.
